Immunogenicity and Safety Study of GSK Biologicals' Combined Measles-Mumps-Rubella-Varicella Vaccine 208136.
Phase of Trial: Phase III
Latest Information Update: 09 Jun 2017
At a glance
- Drugs MMR-varicella zoster virus vaccine (Primary) ; Measles mumps and rubella virus vaccine; Varicella zoster virus vaccine live
- Indications Chickenpox; Measles; Mumps; Rubella; Varicella zoster virus infections
- Focus Pharmacodynamics
- Sponsors GlaxoSmithKline
- 04 Jun 2010 Actual end date (May 2010) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Actual patient number (475) added as reported by ClinicalTrials.gov.
- 04 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.